UMMS Affiliation
Department of Biochemistry and Molecular Pharmacology; Program in Chemical Biology; Thompson Lab
Publication Date
2019-04-19
Document Type
Article Postprint
Disciplines
Amino Acids, Peptides, and Proteins | Biochemistry | Cancer Biology | Enzymes and Coenzymes | Medicinal and Pharmaceutical Chemistry | Medicinal-Pharmaceutical Chemistry
Abstract
Nicotinamide N-methyltransferase (NNMT) catalyzes the S-adenosyl-l-methionine-dependent methylation of nicotinamide to form N-methylnicotinamide. This enzyme detoxifies xenobiotics and regulates NAD+ biosynthesis. Additionally, NNMT is overexpressed in various cancers. Herein, we describe the first NNMT-targeted suicide substrates. These compounds, which include 4-chloropyridine and 4-chloronicotinamide, exploit the broad substrate scope of NNMT; methylation of the pyridine nitrogen enhances the electrophilicity of the C4 position, thereby promoting an aromatic nucleophilic substitution by C159, a noncatalytic cysteine. On the basis of this activity, we developed a suicide inhibition-based protein labeling strategy using an alkyne-substituted 4-chloropyridine that selectively labels NNMT in vitro and in cells. In total, this study describes the first NNMT-directed activity-based probes.
Keywords
Nicotinamide N-methytransferase, NNMT, enzymes, suicide substrates
Rights and Permissions
This document is the Accepted Manuscript version of a Published Work that appeared in final form in ACS Chemical Biology, copyright © 2019 American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see https://doi.org/10.1021/acschembio.9b00211. Accepted manuscript posted after 12 months as allowed by publisher's Journal Publishing Agreement User’s Guide at https://pubs.acs.org/userimages/ContentEditor/1285231362937/jpa_user_guide.pdf.
DOI of Published Version
10.1021/acschembio.9b00211
Source
Sen S, Mondal S, Zheng L, Salinger AJ, Fast W, Weerapana E, Thompson PR. Development of a Suicide Inhibition-Based Protein Labeling Strategy for Nicotinamide N-Methyltransferase. ACS Chem Biol. 2019 Apr 19;14(4):613-618. doi: 10.1021/acschembio.9b00211. Epub 2019 Apr 5. PubMed PMID: 30933557. Link to article on publisher's site
Journal/Book/Conference Title
ACS Chemical Biology
Related Resources
PubMed ID
30933557
Repository Citation
Sen S, Mondal S, Zheng L, Salinger AJ, Fast W, Weerapana E, Thompson PR. (2019). Development of a Suicide Inhibition-Based Protein Labeling Strategy for Nicotinamide N-Methyltransferase. University of Massachusetts Medical School Publications. https://doi.org/10.1021/acschembio.9b00211. Retrieved from https://escholarship.umassmed.edu/publications/15
Fig 1
Fig 2.tif (2587 kB)
Fig 2
Fig 3.tif (3122 kB)
Fig 3
Fig 4.tif (3825 kB)
Fig 4
Supporting Information ver 7.pdf (688 kB)
Supporting Info
Included in
Amino Acids, Peptides, and Proteins Commons, Biochemistry Commons, Cancer Biology Commons, Enzymes and Coenzymes Commons, Medicinal and Pharmaceutical Chemistry Commons, Medicinal-Pharmaceutical Chemistry Commons